OBJECTIVE: Aging is characterized by alterations in body composition such as an increase in body fat and decreases in muscle mass (sarcopenia) and bone density (osteopenia). Leucine supplementation has been shown to acutely stimulate protein synthesis and to decrease body fat. However, the long-term effect of consistent leucine supplementation is not well defined. This study investigated the effect of leucine supplementation during aging. METHODS: Six-month-old rats were divided into three groups: an adult group (n = 10) euthanized at 6 mo of age, a leucine group (n = 16) that received a diet supplemented with 4% leucine for 40 wk, and a control group (n = 19) that received the control diet for 40 wk. The following parameters were evaluated: body weight, food intake, chemical carcass composition, indicators of acquired chronic diseases, and indicators of protein nutritional status. RESULTS: Body weight and fat were lower in the leucine group after 40 wk of supplementation compared with the control group but still higher than in the adult group. The lipid and glycemic profiles were equally altered in the control and leucine groups because of aging. In addition, leucine supplementation did not affect the changes in protein status parameters associated with aging, such as decreases in body and muscle protein and total serum protein. CONCLUSION: The results indicate that leucine supplementation attenuates body fat gain during aging but does not affect risk indicators of acquired chronic diseases. Furthermore, supplemented animals did not show signs of a prevention of the decrease in lean mass associated with aging.
OBJECTIVE: Aging is characterized by alterations in body composition such as an increase in body fat and decreases in muscle mass (sarcopenia) and bone density (osteopenia). Leucine supplementation has been shown to acutely stimulate protein synthesis and to decrease body fat. However, the long-term effect of consistent leucine supplementation is not well defined. This study investigated the effect of leucine supplementation during aging. METHODS: Six-month-old rats were divided into three groups: an adult group (n = 10) euthanized at 6 mo of age, a leucine group (n = 16) that received a diet supplemented with 4% leucine for 40 wk, and a control group (n = 19) that received the control diet for 40 wk. The following parameters were evaluated: body weight, food intake, chemical carcass composition, indicators of acquired chronic diseases, and indicators of protein nutritional status. RESULTS: Body weight and fat were lower in the leucine group after 40 wk of supplementation compared with the control group but still higher than in the adult group. The lipid and glycemic profiles were equally altered in the control and leucine groups because of aging. In addition, leucine supplementation did not affect the changes in protein status parameters associated with aging, such as decreases in body and muscle protein and total serum protein. CONCLUSION: The results indicate that leucine supplementation attenuates body fat gain during aging but does not affect risk indicators of acquired chronic diseases. Furthermore, supplemented animals did not show signs of a prevention of the decrease in lean mass associated with aging.
Authors: Liam McAllan; Paul D Cotter; Helen M Roche; Riitta Korpela; Kanishka N Nilaweera Journal: J Physiol Biochem Date: 2012-04-26 Impact factor: 4.158
Authors: Jamie I Baum; Tyrone A Washington; Stephanie A Shouse; Walter Bottje; Sami Dridi; Gina Davis; Dameon Smith Journal: J Physiol Biochem Date: 2016-08-20 Impact factor: 4.158
Authors: Claire Boutry; Samer W El-Kadi; Agus Suryawan; Julia Steinhoff-Wagner; Barbara Stoll; Renán A Orellana; Hanh V Nguyen; Scot R Kimball; Marta L Fiorotto; Teresa A Davis Journal: Am J Physiol Endocrinol Metab Date: 2016-02-16 Impact factor: 4.310
Authors: Miriam van Dijk; Francina J Dijk; Annelies Bunschoten; Dorien A M van Dartel; Klaske van Norren; Stephane Walrand; Marion Jourdan; Sjors Verlaan; Yvette Luiking Journal: Oncotarget Date: 2016-04-05